ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Japan drugmakers ready as lifestyle diseases emerge in Asia

Demand for tried-and-true treatments expected to rise in China, India

TOKYO -- Japanese pharmaceutical companies are increasingly investing in China, India and other Asian markets outside their home country where lifestyle-related diseases are taking hold.

The companies mostly plan to market drugs that have lost patent protection in Japan. Although less costly generic versions of these drugs are becoming popular, the companies expect Asia's growing income levels to fuel demand.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more